tiprankstipranks
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB
US Market
CMMB
Chemomab Therapeutics
RESEARCH TOOLSreports

Chemomab Therapeutics (CMMB) Financial Statements

326 Followers

Chemomab Therapeutics Financial Overview

Chemomab Therapeutics's market cap is currently $12.30M. The company's EPS TTM is $-0.003; its P/E ratio is -1.71; Chemomab Therapeutics is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $0.00. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -70.56K$ -53.25K$ -66.83K$ -57.77K$ -34.02K
Operating Income$ -9.64M$ -14.74M$ -25.46M$ -28.53M$ -12.37M
EBITDA$ -9.57M$ -13.96M$ -25.39M$ -28.48M$ -12.33M
Net Income$ -9.07M$ -13.95M$ -24.22M$ -27.65M$ -12.48M
Balance Sheet
Cash & Short-Term Investments$ 10.37M$ 14.27M$ 19.78M$ 39.89M$ 61.16M
Total Assets$ 13.81M$ 16.96M$ 22.15M$ 43.06M$ 64.35M
Total Debt$ 0.00$ 324.00K$ 392.00K$ 214.00K$ 343.00K
Net Debt$ -7.56M$ -5.75M$ -8.90M$ -13.30M$ -14.34M
Total Liabilities$ 1.48M$ 3.43M$ 5.15M$ 6.84M$ 2.89M
Stockholders' Equity$ 12.33M$ 13.54M$ 17.00M$ 36.22M$ 61.47M
Cash Flow
Free Cash Flow$ -11.22M$ -15.46M$ -23.55M$ -20.36M$ -12.62M
Operating Cash Flow$ -11.22M$ -15.46M$ -23.55M$ -20.29M$ -12.38M
Investing Cash Flow$ 5.43M$ 2.31M$ 15.84M$ 19.46M$ -45.22M
Financing Cash Flow$ 7.21M$ 9.91M$ 3.49M$ -804.84K$ 61.12M
Currency in USD

Chemomab Therapeutics Earnings and Revenue History

Income Statement >

Chemomab Therapeutics Debt to Assets

Balance Sheet >

Chemomab Therapeutics Cash Flow

Cash Flow >

Chemomab Therapeutics Forecast EPS vs Actual EPS

Earnings >